PPGNY Stock UPDATES Phosphagenics Sp ADR (PPGNY) 2.6500 08/20/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Phosphagenics Sp ADR (PPGNY) 2.6500 $PPGNY

Phosphagenics Completes First Tranche of A$19.3 Million Capital Raising
PR Newswire - Mon Jul 21, 6:00AM CDT
Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), today announced that it has raised A$12.2 million of its A$16.3 million capital raising program. The Company is looking to raise an additional A$3 million from a share purchase plan (SPP) to be offered to existing shareholders.

Global Transdermal Drug Delivery Market 2014-2018 with ANI Pharmaceuticals, Antares Pharma, Bayer, Janssen Pharma & Novartis Dominating
M2 - Wed Jul 16, 9:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sz2mh3/global) has announced the addition of the "Global Transdermal Drug Delivery Market 2014-2018" report to their offering. The Global Transdermal Drug Delivery market will grow at a CAGR of 9.9% Transdermal drug delivery is a large and growing vertical market of the Pharmaceutical industry. Transdermal drug delivery is defined as a system that utilizes skin as a site for continuous drug administration into the systemic circulation. Several methods of transdermal drug delivery include plasters, various ointments and, most commonly, patches. Transdermal drug administration has several advantages. First, the method of delivery is non-invasive, which is much less traumatic to the patient as compared to other forms of drug delivery. Also, it can be effective in assuring that a patient receives a full dosage of a drug and helps in increasing the compliance rate. However, there are difficulties associated with administering medication through the skin. The natural function of the skin is to act as a protective barrier, so it is often the case that drugs are not chemically suitable to penetrating the skin. This report covers the present scenario and the growth prospects of the Global Transdermal Drug Delivery market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs administered transdermally and proprietary transdermal technologies available in the market. The Global Transdermal Drug Delivery market can be divided into five segments: - Smoking Cessation - Pain Management - Hormone Therapy - Cardiovascular Indications - Others Key Vendors - ANI Pharmaceuticals Inc. - Antares Pharma Inc. - Bayer AG - Janssen Pharmaceuticals Inc. - Novartis AG Other Prominent Vendors - 3M Pharmaceuticals Co. - Durect Corp. - Iontera Inc. - Isis Biopolymer Inc. - LTS Lohmann Therapie-Systeme AG - Mylan Laboratories Inc. - Nitto Denko Corp. - Pantec Biosolutions AG - Phosphagenics Ltd. - Tesa Labtec GmbH - Teva Pharmaceutical Industries Ltd. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Competitive Assessment of Transdermal Drugs Delivery Market - Optimisation of Transdermal Drug Delivery - Market Segmentation by Application - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/sz2mh3/global

Global Anti-Aging Product Market 2014-2018 - Skincare Products, Cosmeceuticals, and Hair Care Products
M2 - Wed Jul 16, 8:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7slrvw/global_antiaging) has announced the addition of the "Global Anti-Aging Product Market 2014-2018" report to their offering. The Global Anti-aging Product market will grow at a CAGR of 6.77 percent over the period 2013-2018. Aging is associated with numerous common health problems. Anti-aging products help in fighting the various signs of aging or problems such as wrinkles, blemishes, dry lines, fine color, pores, graying, thinning, and sagging. To overcome these aging problems related to skin and hair consumers use many products that basically fall under three categories: skincare, cosmeceuticals, and hair care. The Global Anti-aging Product market can be divided into three segments: Skincare Products, Cosmeceuticals, and Hair Care Products. These are the product categories used by consumers to reduce various signs of aging and maintain youthfulness. The report, the Global Anti-aging Product Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Anti-aging Product market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Vendors - Beiersdorf AG - L'Or?al SA - Phosphagenics Ltd. - Procter & Gamble Co. - Unilever Group Other Prominent Vendors - Allergan Inc. - Amexdrug Corp. - Avon Products Inc. - Chanel SA - Christian Dior SA - Clarins USA Inc. - DS Healthcare Group Inc. - Elizabeth Arden Inc. - Ella Bach? - Est?e Lauder Co. Inc. - Henkel AG & Co KGaA - Jan Marini Skin Research Inc. - Johnson & Johnson Co. - Kao Corp. - NeoStrata Co. - NuSKin Enterprises - Orlane SA - Revlon Inc. - Robanda International Inc. - Shiseido Co. - SkinMedica Inc. - Skinvisible Inc. - Woodridge Labs Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Demographic Segmentation - Market Segmentation by Product - Geographical Segmentation - Key Leading Countries - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/7s..._antiaging

Phosphagenics' A$19.3 million Capital Raising
PR Newswire - Fri Jul 11, 8:30AM CDT
Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), today announced that it has raised A$19.3 million via a placement of A$16.3 million to institutional investors in Europe, the U.S., Asia and Australia and A$3 million from a share purchase plan (SPP) to be offered to existing shareholders. The placement of A$16.3 million will be made in two tranches.

Phosphagenics to Host Investor Call on Wednesday, April 2nd at 4:00pm EDT (USA)
PR Newswire - Wed Mar 26, 7:00AM CDT
Phosphagenics Limited (ASX: POH) (OTCQX: PPGNY) ("Phosphagenics" or "the Company" announced today that management will host an investor conference call and webcast to discuss the commercial opportunities arising from a range of innovative analgesic products emerging from the Company's patented TPM® drug delivery technology. The Company will describe how TPM® is enabling it to establish a unique competitive position in the transdermal and topical delivery of diverse analgesics, including oxymorphone and oxycodone. The Company will review current success stories, ongoing and future development plans, and the commercial opportunity for unique and innovative products that overcome the limitations of analgesics currently on market.

'Acne Vulgaris - Pipeline Review, H2 2013' Contains Discovery and Pre-Clinical Stage Products
M2 - Tue Sep 03, 10:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mddqlt/acne_vulgaris) has announced the addition of the "Acne Vulgaris - Pipeline Review, H2 2013" report to their offering. Global Markets Direct's, 'Acne Vulgaris - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acne Vulgaris, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acne Vulgaris. Scope - A snapshot of the global therapeutic scenario for Acne Vulgaris. - A review of the Acne Vulgaris products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Acne Vulgaris pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Companies Mentioned Normal 0 false false false MicrosoftInternetExplorer4 Advancell AndroScience Corporation AntiCancer, Inc. Ausio Pharmaceuticals, LLC Boehringer Ingelheim GmbH Braintree Laboratories, Inc. Ensoltek Co., Ltd. Foamix Ltd. Galderma S.A. Hygeia Therapeutics, Inc. Lee's Pharmaceutical Holdings Limited Maruho Co.,Ltd. Medicis Pharmaceutical Corporation NanoBio Corporation Phosphagenics Limited Photocure ASA Quest PharmaTech Inc. Toyama Chemical Co. Ltd Valeant Pharmaceuticals International XBiotech USA, Inc. XOMA Ltd. For more information visit http://www.researchandmarkets.com/research/md...ne_vulgari About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Phosphagenics Signs Research Agreement with the Agricultural Research Service
PR Newswire - Mon May 20, 7:00AM CDT
-- Collaboration with the U.S. Department of Agriculture's (USDA) Agricultural Research Service (ARS) in treatment of mastitis




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mudrick Urges Doncasters to Test a Strategic Sale Now

Updated Category News Views 81

Castings are rarely glamorous until nobody can get them, and Mudrick Capital is betting that ugly little industrial reality could make Doncasters worth far more in a takeover than the market currently credits. The event-driven investor, which says it owns roughly 4.3% of DPC Holdings Limited, has asked the board to quietly evaluate strategic alternatives, including a sale...

Continue Reading
Vanguard's Digital Win Matters More Than a Trophy

Updated Category News Views 182

A wealth manager’s website rarely earns applause, but a bad one can sure as hell lose trust fast. Vanguard’s move to No. 1 from No. 3 in the 2025 ranking for advised-investor website satisfaction is worth noticing because it hits the unglamorous part of wealth management that clients actually live with: checking accounts, understanding a plan, moving cash, and...

Continue Reading
BreakBio's New CSO Adds Vaccine Trial Credibility in Cancer

Updated Category News Views 144

Personalized cancer vaccines have no shortage of grand promises; seasoned clinical operators are the rarer commodity. That is why BreakBio's appointment of Dr. Greg Lizée as chief scientific officer deserves a closer look, even if nobody should confuse an executive hire with clinical validation. BreakBio is private, its lead program remains in development, and cancer...

Continue Reading
Point72 Breach Puts Cyber Controls Under the Microscope

Updated Category News Views 76

Two compromised user accounts can turn a supposedly contained cyber problem into a boardroom headache in a hurry. Point72 Asset Management, the global alternative-investment firm founded by Steven A. Cohen in 2014, has reported a social-engineering incident involving accounts that were used to copy files from limited portions of its IT systems. This is not a trading-loss...

Continue Reading
Green Lumber Recall Raises a Serious Safety Question

Updated Category News Views 41

A blister-pack code is doing far more work than it ever should. Green Lumber Holdings is recalling Green Lumber Natural Fuel For Men, lot GL01 with expiration 09/27, after FDA laboratory analysis confirmed undeclared tadalafil in additional samples. The company says the consumer-level recall begins November 19, 2026. This is not a cute labeling nitpick or a marketing...

Continue Reading
Dario's WebMD Deal Opens a Vast, Unproven Channel Path

Updated Category News Views 141

One partnership can look like a gold mine from across the valley; getting the ore out is another matter entirely. DarioHealth has struck a strategic partnership with WebMD Health Services that could put its multi-condition care platform in front of an enormous commercial ecosystem: more than 3,500 employers and 65 million covered lives. That is a meaningful distribution...

Continue Reading
PBS Holiday Special Bets on Apollo 8, Music and Unity

Updated Category News Views 54

A moon mission, a 360-voice choir, and Christmas television make an unusual bundle, but that is precisely why this year’s Tabernacle Choir special has some real staying power. Peace on Earth: Christmas with The Tabernacle Choir is not trying to chase whatever noisy trend is chewing up attention this week. It is building a 90-minute holiday event around Apollo 8,...

Continue Reading
ACOLT Bets on Gold, Craft, and a Sci-Fi Story World

Updated Category News Views 123

A gold pendant moonlighting as a plot device is not the usual luxury pitch, and thank goodness for that. ACOLT, the Denver-based men's fine jewelry house founded by Colton Hindle, plans an international December 2026 launch of its Gold Collection alongside CHRYSON Volume 1: The Arrival, an original science-fiction comic. The actual hand-forged pieces are meant to show up...

Continue Reading
Refund Delays Are Becoming an E-Commerce Sales Risk

Updated Category News Views 176

A returned jacket can turn into a household cash-flow problem faster than retailers seem willing to admit. Seel's new survey lands at an awkward moment for online merchants: shoppers are not merely annoyed by slow refunds; many are budgeting around them. Among 1,921 U.S. adults who had shopped online in the prior six months, 63% said waiting for a retailer to receive a...

Continue Reading
L’Oréal’s Women of Worth Shows Why Brand Patience Matters

Updated Category News Views 120

Twenty-one years is a long time to keep a corporate promise from turning into wallpaper. L’Oréal Paris gathered its 2026 Women of Worth class at the Ebell in Los Angeles on November 18, recognizing 10 nonprofit leaders working on problems that do not yield to a glitzy evening or a tidy slogan. That distinction matters. Cancer survivorship, trafficking prevention,...

Continue Reading

Top 5 Most Recently Viewed Articles

India's AI Market: Open Source Fueling Massive Growth

Updated Category News Views 195

February 17, 2026, and the buzz is all about India’s AI landscape—open source is the name of the game. The Linux Foundation just dropped a hefty report claiming India’s AI market will skyrocket from $6 billion in 2024 to nearly $32 billion by 2031. Seriously, that’s some jaw-dropping growth fueled by a mix of homegrown talent, strong government support, and an...

Continue Reading
Growth Projections for the Expanding UV LED Market

Updated Category News Views 115

Understanding the UV LED Market Surge The UV LED market is witnessing a remarkable transformation, with projections indicating it will reach a valuation of USD 2.16 billion by 2030. This trend marks a substantial growth from its anticipated value of USD 1.23 billion in 2025, leading to a compound annual growth rate (CAGR) of 11.9%. Key Factors Driving Market Growth The...

Continue Reading
Microsoft Partners with Constellation to Restart Three Mile Island

Updated Category News Views 136

Revitalizing Three Mile Island with Innovative Solutions Constellation Energy has teamed up with Microsoft (NASDAQ: MSFT) in an exciting partnership aimed at restarting a unit of the Three Mile Island nuclear plant in Pennsylvania. This initiative marks the first attempt to revive a retired nuclear facility, showcasing the changing dynamics in energy solutions. As...

Continue Reading
Investigation of WideOpenWest, Inc. Over Potential Wrongdoing

Updated Category News Views 152

WideOpenWest, Inc. Under Investigation for Fiduciary Breaches The DJS Law Group has initiated an investigation on behalf of investors regarding WideOpenWest, Inc. (NYSE: WOW). This investigation is focused on potential breaches of fiduciary duty that may have occurred within the company's board of directors and management. The aim is to determine if the directors have...

Continue Reading
Guidehouse Earns Recognition as Celonis Partner of the Year

Updated Category News Views 266

Guidehouse Recognized as Celonis Public Sector Partner of the Year Innovation is at the forefront of modern public sector operations, and Guidehouse has made significant strides in this area. The firm was honored with the Celonis Public Sector Partner of the Year award, showcasing its dedication to transforming government processes through advanced technology. Leading...

Continue Reading